Geri Dön

Tip 1 ve tip 2 diyabetli hastaların diyabet tutumunun değerlendirilmesi

Evaluation of the attitudes of type 1 and type 2 diabetic patients

  1. Tez No: 193403
  2. Yazar: MAHROKH JAVANSHİR
  3. Danışmanlar: PROF.DR. ZEHRA DURNA
  4. Tez Türü: Yüksek Lisans
  5. Konular: Hemşirelik, Nursing
  6. Anahtar Kelimeler: STZ-diabetes, Kidney, Clusterin, Apoptosis, STZ-diabetes, Kidney, Clusterin, Apoptosis
  7. Yıl: 2006
  8. Dil: Türkçe
  9. Üniversite: İstanbul Üniversitesi
  10. Enstitü: Sağlık Bilimleri Enstitüsü
  11. Ana Bilim Dalı: İç Hastalıkları Hemşireliği Ana Bilim Dalı
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: Belirtilmemiş.

Özet

XVABSTRACTTunçdemir M. The effects of ACE inhibitor and angiotensin receptor blocker onclusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats. İstanbulUniversity, Institute of Health Science, Medical Biology Dept. Ph.D.Thesis. Istanbul2006.The aim of this study was to determine the roles of secreted clusterin (s-clu) and nuclearclsuterin (n-clu) expressions in experimental diabetic nephropathy, and to investigatethe effects on clusterins expression after treatment angiotensin II blockade and comparethese results with apoptosis. Five groups, each containing 8 male Wistar albino ratswere included in this study. Four groups received streptozotocin injection (STZ, 60mg/kg, single dose, ip). On the 2nd day of STZ injection the rats developing diabeteswere divided into 4 groups. First group was STZ-diabetic. Second group was irbesartantreated diabetics (15 mg/kg/day, gavage, 30 days). Third group was perindopril treateddiabetics (6 mg/kg/day, gavage, 30 days), Fourth group was combined treated diabeticgroup with perindopril and irbesartan (respectively, 3 mg/kg/day, 5 mg/kg/day, gavage,30 days). Fifth group was the healthy control. During the experimental period bloodglucose, microalbuminuria levels, body weights, kidney weight and amount of dailyurine were measured. At the end of experiment, renal tissue samples were fixed informaline and embedded in paraffin. PAS staining and TUNEL method andimmunohistochemical staining for TGF-β1, α-SMA, clusterin-β (for s-clu) andclusterin-α/β (for n-clu) antigenes were performed for histological examinations. Bloodglucose levels and body weight/kidney weight values of all STZ-diabetic groups werehigher than the healthy control group. The level of daily urine and microalbuminurialevels were decreased in the all treated diabetic groups (p<0,001). As the number ofapoptotic cells increased especially in the kidney tubules of STZ-diabetic group(p<0,001), whereas a significant decrease was observed in the combined drug treatedgroup (p<0,05). When compared with the untreated diabetic group the expressions ofTGF-β1 and α-SMA were decreased in the all treated diabetic group. The expression ofclusterin-β was increased in the glomerules and tubules of the untreated diabetic group,although it was decreased in the treated diabetic groups. Immunopositivity ofclusterin-α/β in the podocytes and mesangial cells and in the injured tubule cells ofuntreated diabetic group was found to be increased in their nuclei. The number ofXVIimmunopositive cells was decreased in the treated diabetic groups, especially in thecombined treated diabetic group (p<0,05). It was concluded that, the increase in theexpression of TGF-β1 and α-SMA in glomeruli was a marker of renal injury, seen inthe early stages of diabetes as a result of damage caused by local increased expressionof RAS in the renal tissue induced by hyperglycemia. In the early stages of diabetes,the increase in the number of the apoptotic cells in the tubules, seen was one of thecauses of tubular damage. Our results also show that the expression of s-clu wasinduced in the experimental diabetic nephropathy related to renal tissue damage and thatthe increase in the n-clu expression in the renal tubules was releated to apoptosis.Although irbesartan (AT-1R blocker), perindopril (ACEI) and combined drug treatmentprevented renal injury in the diabetes, low dose application of ACEI and AT-1R blockertogether revealed more efficient results in preventing renal damages.

Özet (Çeviri)

XVABSTRACTTunçdemir M. The effects of ACE inhibitor and angiotensin receptor blocker onclusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats. İstanbulUniversity, Institute of Health Science, Medical Biology Dept. Ph.D.Thesis. Istanbul2006.The aim of this study was to determine the roles of secreted clusterin (s-clu) and nuclearclsuterin (n-clu) expressions in experimental diabetic nephropathy, and to investigatethe effects on clusterins expression after treatment angiotensin II blockade and comparethese results with apoptosis. Five groups, each containing 8 male Wistar albino ratswere included in this study. Four groups received streptozotocin injection (STZ, 60mg/kg, single dose, ip). On the 2nd day of STZ injection the rats developing diabeteswere divided into 4 groups. First group was STZ-diabetic. Second group was irbesartantreated diabetics (15 mg/kg/day, gavage, 30 days). Third group was perindopril treateddiabetics (6 mg/kg/day, gavage, 30 days), Fourth group was combined treated diabeticgroup with perindopril and irbesartan (respectively, 3 mg/kg/day, 5 mg/kg/day, gavage,30 days). Fifth group was the healthy control. During the experimental period bloodglucose, microalbuminuria levels, body weights, kidney weight and amount of dailyurine were measured. At the end of experiment, renal tissue samples were fixed informaline and embedded in paraffin. PAS staining and TUNEL method andimmunohistochemical staining for TGF-β1, α-SMA, clusterin-β (for s-clu) andclusterin-α/β (for n-clu) antigenes were performed for histological examinations. Bloodglucose levels and body weight/kidney weight values of all STZ-diabetic groups werehigher than the healthy control group. The level of daily urine and microalbuminurialevels were decreased in the all treated diabetic groups (p<0,001). As the number ofapoptotic cells increased especially in the kidney tubules of STZ-diabetic group(p<0,001), whereas a significant decrease was observed in the combined drug treatedgroup (p<0,05). When compared with the untreated diabetic group the expressions ofTGF-β1 and α-SMA were decreased in the all treated diabetic group. The expression ofclusterin-β was increased in the glomerules and tubules of the untreated diabetic group,although it was decreased in the treated diabetic groups. Immunopositivity ofclusterin-α/β in the podocytes and mesangial cells and in the injured tubule cells ofuntreated diabetic group was found to be increased in their nuclei. The number ofXVIimmunopositive cells was decreased in the treated diabetic groups, especially in thecombined treated diabetic group (p<0,05). It was concluded that, the increase in theexpression of TGF-β1 and α-SMA in glomeruli was a marker of renal injury, seen inthe early stages of diabetes as a result of damage caused by local increased expressionof RAS in the renal tissue induced by hyperglycemia. In the early stages of diabetes,the increase in the number of the apoptotic cells in the tubules, seen was one of thecauses of tubular damage. Our results also show that the expression of s-clu wasinduced in the experimental diabetic nephropathy related to renal tissue damage and thatthe increase in the n-clu expression in the renal tubules was releated to apoptosis.Although irbesartan (AT-1R blocker), perindopril (ACEI) and combined drug treatmentprevented renal injury in the diabetes, low dose application of ACEI and AT-1R blockertogether revealed more efficient results in preventing renal damages.

Benzer Tezler

  1. Tip 2 diyabetli hastaların bakım ve tedaviye yönelik tutum ve davranışlarının incelenmesi

    Examination of type 2 diabetics attitudes and behaviours against care and treatment

    SAKİNE USTAALİOĞLU

    Yüksek Lisans

    Türkçe

    Türkçe

    2015

    HemşirelikAtatürk Üniversitesi

    İç Hastalıkları Hemşireliği Ana Bilim Dalı

    PROF. DR. MEHTAP TAN

  2. Samsun E tipi kapalı ceza infaz kurumundaki diyabetli hükümlü/ tutuklu ve personelin diyabet bakım profilleri ile metabolik kontrol değişkenlerinin incelenmesi

    Examination of metabolic control variables and diabetes care profiles of diabetic concicted prisoner and staff in Samsun E type closed institute of execution

    GÜL MADEN

    Yüksek Lisans

    Türkçe

    Türkçe

    2018

    HemşirelikHasan Kalyoncu Üniversitesi

    Hemşirelik Ana Bilim Dalı

    PROF. DR. NERMİN OLGUN

  3. Tip 2 diyabet hastalarının ayak bakımı hakkında bilgi, tutum ve davranışlarının değerlendirilmesi

    Evaluation of knowledge, attitudes and behaviors of type 2 diabetes patients about foot care

    HÜLYA SOYTÜRK KESKİN

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2024

    Aile HekimliğiSağlık Bilimleri Üniversitesi

    Aile Hekimliği Ana Bilim Dalı

    DR. ZEYNEP AŞIK

  4. Tip 2 diyabetli bireylerin öz-etkililik düzeyleri ve sağlık kontrol odağı ile ilişkisi

    Self-efficiency levels of individuals with TYPE 2 diabetes and rrelationship with health locus of control

    MUSTAFA KILIÇ

    Yüksek Lisans

    Türkçe

    Türkçe

    2016

    HemşirelikSelçuk Üniversitesi

    Hemşirelik Ana Bilim Dalı

    YRD. DOÇ. DR. SELDA ARSLAN

  5. Doğumsal brakiyal pleksus paralizili hastalarımızın retrospektif değerlendirilmesi

    Retrospective evaluation of our patients with neonatal brachial plexus palsy birth injury

    YÜKSEL DEMİREL

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2022

    Çocuk Sağlığı ve HastalıklarıÇukurova Üniversitesi

    Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı

    PROF. DR. FARUK İNCECİK